...
首页> 外文期刊>Seminars in Arthritis and Rheumatism >Posterior reversible encephalopathy syndrome: an emerging disease manifestation in systemic lupus erythematosus.
【24h】

Posterior reversible encephalopathy syndrome: an emerging disease manifestation in systemic lupus erythematosus.

机译:后可逆性脑病综合征:系统性红斑狼疮的一种新兴疾病表现。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: Posterior reversible encephalopathy syndrome (PRES) is a rare feature of systemic lupus erythematosus (SLE) that can present with seizures, visual disturbance, and/or hypertension. We describe 7 new cases of PRES in SLE patients that highlight some of the diagnostic and treatment dilemmas of this condition. METHODS: We obtained informed consent from patients for the review of their cases. A comprehensive literature search was done to find all published cases of PRES in SLE and these were compared with our cohort. RESULTS: Including our series, there are 66 cases of PRES in SLE patients published in the English literature to date. Our series had 2 main distinguishing features when compared with the available literature: only 43% of our patients presented with seizures compared with 83 to 95% in the reported literature and over 50% of our cases of PRES occurred in newly diagnosed SLE. CONCLUSIONS: PRES is a more frequent feature of SLE than previously thought and may be 1 of the presenting manifestations of SLE. Whether PRES is a manifestation of SLE disease activity and of its treatment or whether it represents a neuropsychiatric manifestation of SLE remain to be determined. Consequently there continues to be controversy as to whether immunosuppression should be used in addition to supportive measures in the treatment of PRES in SLE.
机译:目的:后可逆性脑病综合征(PRES)是系统性红斑狼疮(SLE)的罕见特征,可伴有癫痫发作,视力障碍和/或高血压。我们描述了SLE患者中的7例PRES新病例,这些病例突出了该病的一些诊断和治疗难题。方法:我们获得了患者的知情同意,以对其病例进行复查。进行了全面的文献检索,以查找SLE中所有已发表的PRES病例,并将其与我们的队列进行比较。结果:包括我们的系列文献在内,迄今为止,在英语文献中已有66例SLE患者的PRES病例。与现有文献相比,我们的系列具有两个主要区别特征:只有43%的患者出现癫痫发作,而文献报道的患者为83%至95%,并且超过50%的PRES病例发生在新诊断的SLE中。结论:PRES是SLE较以前认为的更为常见的特征,可能是SLE的表现之一。 PRES是否是SLE疾病活动及其治疗的表现还是它是否代表SLE的神经精神病表现尚待确定。因此,在治疗SLE中的PRES时,除了支持措施外,是否还应使用免疫抑制仍存在争议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号